![](https://d3ilqtpdwi981i.cloudfront.net/DlMk5zRgde67ukG500XkmS4VhU4=/425x550/smart/https://bepress-attached-resources.s3.amazonaws.com/uploads/70/da/2f/70da2f3b-3fff-4185-8169-228d888ef66d/thumbnail_BPFile%20object.jpg)
Capsules of Pasteurella multocida serogroups A, D and F contain mucopolysaccharides which block antigenic determinants and prevent phagocytosis. In this study, capsules of serogroup A, D and F strains of P. multocida were depolymerized by enzyme treatment. Capsule depolymerization of serogroup D and F strains with chondroitinase increased indirect hemagglutination (IHA) test titers and enhanced phagocytosis by swine neutrophils. Capsule depolymerization of serogroup A strains with hyaluronidase increased IHA titers, but depolymerization with chondroitinase did not. When serogroup A strains were treated with a combination of chondroitinase and hyaluronidase, IHA test titers were lower than titers of the same strains treated with hyaluronidase alone. Combined enzyme treatment of serogroup D strains resulted in IHA test titers similar to those of chondroitinase treatment alone.
- Pasteurella multocida,
- Serology,
- Phagocytosis,
- Capsule,
- Chondroitinase
Available at: http://works.bepress.com/mark_ackermann/73/